Visikol Accelerates Growth with Relocation to New Facility
Mike Johnson2019-02-21T01:30:52-05:00WHITEHOUSE, N.J. (PRWEB) MAY 14, 2018 The move is a key milestone that will enable the company to expand its [...]
Visikol Launches Oncology Drug Screening Services Through its 3Screen™ Portfolio
Mike Johnson2019-07-24T13:47:20-05:00WHITEHOUSE, N.J. (PRWEB) JUNE 6, 2018 Recently, Visikol, a contract research organization focused on digital pathology and optical imaging built [...]
Visikol Receives $450,000 in Funding from the National Institutes of Health and National Science Foundation
Mike Johnson2019-02-21T01:30:52-05:00The Visikol team is proud to announce that it has secured two SBIR grants from the NIH and NSF for [...]
Enzyvant Announces Collaboration with Visikol to Develop Innovative Digital Pathology Assay to Support RVT-802 Development
Mike Johnson2019-02-21T01:30:52-05:00BASEL, Switzerland and WHITEHOUSE STATION, N.J. /PRWEB/ -- July 5, 2018 Enzyvant, a biopharmaceutical company focused on developing innovative treatments [...]
Forbes Spotlight on Visikol and CEO Dr. Michael Johnson
Mike Johnson2019-02-21T01:30:52-05:00Visikol CEO and Co-Founder Dr. Michael Johnson was named to the Forbes 30 Under 30 list in 2017 and was [...]
Visikol Machine Learning Digital Pathology Services for Drug Discovery
Mike Johnson2019-02-21T02:48:40-05:00WHITEHOUSE STATION, N.J. (PRWEB) OCTOBER 15, 2018 Since the inception of the microscope, researchers and clinicians have characterized tissues through [...]
Thermo Fisher Scientific Webinar Highlighting Visikol’s 3D Cell Culture Assays On Demand for Download
Mike Johnson2019-02-21T01:30:52-05:00If you missed Thermo Fisher Scientific's webinar on LabRoots that focused on Visikol and Visikol's 3D cell culture assays you [...]
Come Check Out Visikol’s Science Exchange Webinar on Advanced Imaging and Image Analysis Services
Mike Johnson2019-02-21T01:30:53-05:00On October 25th at 12:00 PM EST Dr. Michael Johnson from Visikol will be presenting a webinar sponsored by Science [...]